In a first for Australia, a pathology lab was given authorization to use patient-collected cervical specimens from eligible women for cervical cancer screening purposes. VCS Pathology of Melbourne, Victoria, was given this authorization by Australia’s National Association of Testing Authorities (NATA). Other pathology labs in Australia are expected to be granted similar authorization in coming months. It is believed that self-collection will encourage more women to participate in cervical cancer screening programs.
MAYO CLINIC, WUXI APPTEC FORM JV IN CHINA
Earlier this month, Mayo Clinic and WuXi AppTec Group of Shanghai, China, announced a joint venture “to develop and deliver clinical diagnostics in China.”
HOSPITAL C-SUITE SALARIES TO BE TAXED AT NEW RATE
There’s an interesting twist in the new tax reform law. Tax-exempt hospitals will now need to pay a 20% excise tax on compensation that exceeds $1 million per year that is paid to their five highest-paid employees (but not on compensation from the direct provision of medical services).
- Aeon Global Health announced that pathologist Armando Moncada, MD, FCAP, was appointed as its new Chief Medical Officer. Moncada formerly served at PCG Molecular, Lea Regional Medical Center, and Baylor College of Medicine.
- Precipio, Inc., of New Haven, Conn., selected Douglas Sites to be its new Vice President of Sales. Sites previously held sales and marketing positions at Rosetta Genomics, Asuragen, and Plus Diagnostics.
- Last month, attorney and Senior Counsel Peter Kazon retired from Alston and Bird, the Washington, DC-based law firm to “pursue new interests.” Among his clients was the American Clinical Laboratory Association (ACLA).
- Immucor’s new CEO and President is Avi Pelossof. His previous executive positions were at Alere, Chembio Diagnostics Systems, IMS Group, and Citibank.
- Clinical Genomics of Bridgewater, N.J., announced that Tadd S. Lazarus, MD, was named its Chief Medical Officer. Lazarus previously served as CMO or MO at Luminex Corporation, Quiagen, Gen-Probe, and Roche Diagnostics.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, February 12, 2018.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…why many researcher teams are working in the field of nano-scale diagnostics to go beyond “lab-on-a-chip” and create “lab-on-skin” testing devices capable of monitoring many biomarkers used in clinical laboratory testing.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.